Insmed Inc (INSM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 40.31 is considered Overvalued compared with the five-year average of -11.00. The fair price of Insmed Inc (INSM) is between 55.98 to 122.18 according to relative valuation method. Compared to the current price of 146.32 USD , Insmed Inc By Overvalued By 19.76%.

Relative Value

Fair Zone

55.98-122.18

Current Price：146.32

19.76%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Insmed Inc (INSM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Insmed Inc (INSM) has a current Price-to-Book (P/B) ratio of 39.82. Compared to its 3-year average P/B ratio of 48.09, the current P/B ratio is approximately -17.20% higher. Relative to its 5-year average P/B ratio of 31.48, the current P/B ratio is about 26.49% higher. Insmed Inc (INSM) has a Forward Free Cash Flow (FCF) yield of approximately -2.40%. Compared to its 3-year average FCF yield of -9.18%, the current FCF yield is approximately -73.86% lower. Relative to its 5-year average FCF yield of -10.49%, the current FCF yield is about -77.14% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for INSM competitors is 42.69, providing a benchmark for relative valuation. Insmed Inc Corp (INSM.O) exhibits a P/S ratio of 40.31, which is -5.57% above the industry average. Given its robust revenue growth of 152.62%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of INSM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of INSM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is INSM currently overvalued or undervalued?

What is Insmed Inc (INSM) fair value?

INSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Insmed Inc (INSM) is between 55.98 to 122.18 according to relative valuation method.

How does INSM's valuation metrics compare to the industry average?

The average P/S ratio for INSM's competitors is 42.69, providing a benchmark for relative valuation. Insmed Inc Corp (INSM) exhibits a P/S ratio of 40.31, which is -5.57% above the industry average. Given its robust revenue growth of 152.62%, this premium appears sustainable.

What is the current P/B ratio for Insmed Inc (INSM) as of Mar 03 2026?

As of Mar 03 2026, Insmed Inc (INSM) has a P/B ratio of 39.82. This indicates that the market values INSM at 39.82 times its book value.

What is the current FCF Yield for Insmed Inc (INSM) as of Mar 03 2026?

As of Mar 03 2026, Insmed Inc (INSM) has a FCF Yield of -2.40%. This means that for every dollar of Insmed Inc's market capitalization, the company generates -2.40 cents in free cash flow.

What is the current Forward P/E ratio for Insmed Inc (INSM) as of Mar 03 2026?

As of Mar 03 2026, Insmed Inc (INSM) has a Forward P/E ratio of -40.55. This means the market is willing to pay $-40.55 for every dollar of Insmed Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Insmed Inc (INSM) as of Mar 03 2026?

As of Mar 03 2026, Insmed Inc (INSM) has a Forward P/S ratio of 40.31. This means the market is valuing INSM at $40.31 for every dollar of expected revenue over the next 12 months.

INSM Valuation